0 Comments
0 Shares
292 Views
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Asia-Pacific Rare Disease Treatment Market: Opportunities in Gene Therapy, Cell Therapy & BiologicsMarket Overview The global Rare Disease Treatment Market is projected to grow from approximately USD 187.3 billion in 2025 to USD 461.7 billion by 2035, registering a CAGR of 9.4%. The market is expanding due to advances in biologics, gene therapies, precision medicine, and targeted treatments, along with improving diagnosis and awareness of rare diseases. Biologics accounted for approximately...0 Comments 0 Shares 221 Views
-
Biopharmaceuticals Market Trends: Cell & Gene Therapy and Biologics Fuel Growth Across the US, Europe & APACMarket Overview According to MarketGenics, the global Biopharmaceuticals Market is valued at USD 447.2 billion in 2025 and is projected to reach USD 839.4 billion by 2035, registering a CAGR of 6.5% during the forecast period. The market is experiencing robust growth due to the increasing demand for biologic therapies, rising prevalence of chronic and rare diseases, and continuous...0 Comments 0 Shares 258 Views
-
Bioprocess Technology Market Advanced by Cell and Gene Therapy Scale-Up Platforms and Automated BioreactorsThe rapid commercialization of advanced therapy medicinal products (ATMPs) is creating significant demand for automated, scalable bioprocessing systems. Detailed analysis within the Bioprocess Technology Market report reveals that automated closed-system bioreactors enable safe, reproducible expansion of T-cells, stem cells, and viral vectors. Automating cell processing minimizes manual...0 Comments 0 Shares 216 Views
-
Cell & Gene Therapy Contract Research Organizations Market Forecast Highlights Innovation and Strategic PartnershipsThe rapid advancement of cell and gene therapies is transforming the future of modern medicine by offering highly targeted treatments for cancer, rare genetic disorders, autoimmune diseases, and inherited conditions. As these therapies become increasingly complex, pharmaceutical and biotechnology companies are relying on specialized contract research organizations (CROs) to accelerate product...0 Comments 0 Shares 223 Views
-
Cell & Gene Therapy Contract Research Organizations Market: Accelerating Advanced Therapy Development Through CRO ServicesThe rapid advancement of biotechnology, increasing demand for personalized medicine, and growing investment in innovative therapies are driving significant transformation across the healthcare industry. The rise of complex treatments such as gene therapies, cell-based therapies, CAR-T therapies, and regenerative medicines has created a strong need for specialized research partners with advanced...0 Comments 0 Shares 206 Views
-
Cell and Gene Therapy and the Biologic Therapy MarketCell and gene therapies represent the most ambitious frontier of the biologic therapy market. Rather than managing symptoms, these treatments aim to correct disease at its genetic or cellular source — potentially offering one-time cures for conditions that previously required lifelong management. CAR-T therapies for blood cancers, gene therapies for inherited disorders, and emerging...0 Comments 0 Shares 31 Views
-
Cell and Gene Therapy Bioassay Services Market Trends: Innovation and Competitive LandscapeThe Cell and Gene Therapy Bioassay Services Market trends indicate a strong focus on innovation and technological advancement. Companies are investing in developing advanced assay techniques that can handle the complexity of cell and gene therapies. The use of artificial intelligence and machine learning is improving data analysis and enhancing assay accuracy. These innovations are helping...0 Comments 0 Shares 243 Views
-
Cell and Gene Therapy CDMO Market Outlook and Industry DynamicsThe Cell and Gene Therapy CDMO market is experiencing transformative changes, currently valued at USD 35.89 billion in 2024 and projected to soar to USD 366.93 billion by 2035, reflecting a staggering CAGR of 23.53%. As personalized medicine becomes more prevalent, stakeholders are keenly observing the emerging trends shaping this sector. indicates that these trends are pivotal, not only in...0 Comments 0 Shares 227 Views
-
Cell and Gene Therapy CDMO Market Trends: Innovation and Competitive LandscapeThe Cell and Gene Therapy CDMO Market trends indicate a strong focus on innovation and expansion of manufacturing capabilities. Companies are investing in advanced facilities and technologies to meet the growing demand for cell and gene therapy production. The development of scalable manufacturing processes is becoming a key priority, as it enables the commercialization of therapies on a larger...0 Comments 0 Shares 288 Views
-
Cell And Gene Therapy Clinical Trials Market Insights: Key Drivers, Challenges, and Competitive LandscapeMarket Overview The global Cell and Gene Therapy Clinical Trials Market is experiencing significant growth due to increasing investments in advanced therapies, rising prevalence of chronic and genetic disorders, and rapid advancements in biotechnology research. Cell and gene therapies represent a new generation of medical treatments designed to address the underlying causes of diseases...0 Comments 0 Shares 235 Views
-
Cell and Gene Therapy QC & Analytics Market: Accelerating Advanced Therapy Manufacturing with Next-Generation Analytics by 2034Potency testing is becoming an important area of innovation within the market. Cell and gene therapy developers require assays capable of demonstrating relevant biological activity and supporting product consistency. The development of mechanism-of-action-related potency assays remains an important analytical challenge across advanced therapy programs. The Cell and Gene Therapy QC &...0 Comments 0 Shares 189 Views
-
Andersen Disease Treatment Market: Advancing Rare Genetic Disorder TherapiesAccording to the latest report published by Data Bridge Market Research, the Andersen Disease Treatment Market CAGR Value As per Data Bridge Market Research Analysis The global andersen disease treatment market size was valued at USD 1.27 billion in 2025 and is expected to reach USD 2.05 billion by 2033, at a CAGR of 6.20% during the forecast period Andersen Disease...0 Comments 0 Shares 198 Views
-
Bioprocess Technology Market: Transforming Biopharmaceutical Manufacturing and Biologics ProductionAccording to the latest report published by Data Bridge Market Research, the Bioprocess Technology Market CAGR Value As per Data Bridge Market Research analysis The bioprocess technology market was valued at USD 24.68 billion in 2025 and is projected to reach USD 48.45 billion by 2033, growing at a CAGR of 8.80% from 2026 to 2033. The market research data involved in the...0 Comments 0 Shares 234 Views
-
Cellular and Gene Therapy Product Market Research: Regional Insights and Industry OverviewThe Cellular and Gene Therapy Product Market research highlights strong regional differences in adoption and development. North America leads the market due to advanced healthcare infrastructure, strong research capabilities, and high investment in biotechnology. The presence of major pharmaceutical and biotech companies further strengthens its dominance. Europe also shows significant growth,...0 Comments 0 Shares 206 Views
-
Gene Therapy for Age-Related Macular Degeneration Market – Genetic Medicine Targeting Vision PreservationMarket Overview The gene therapy for age-related macular degeneration market is emerging as researchers develop genetic interventions targeting the underlying biological mechanisms of vision loss in aging populations. These therapies aim to deliver long-lasting or one-time treatment effects, contrasting with the recurring injection regimens common in current AMD management. The Gene Therapy For...0 Comments 0 Shares 121 Views
-
Gene Therapy for Ultra-Rare Diseases Market Outlook: Innovation in Precision MedicineMarket Overview The global Gene Therapy for Ultra-Rare Diseases Market is gaining attention as advances in genetic medicine create new possibilities for treating rare inherited conditions that often have limited treatment options. One published market estimate values this specialized market at USD 0.3 billion in 2025 and projects it to reach USD 0.7 billion by 2035, representing a CAGR of 8.4%...0 Comments 0 Shares 51 Views
-
Gene Therapy Market to Grow from US$ 3.75 Billion in 2025 to US$ 19.75 Billion by 2033The gene therapy industry is becoming increasingly important as biopharmaceutical companies and healthcare systems focus on durable, potentially curative treatment options for genetically driven diseases. These therapies support demanding applications across rare monogenic disorders, inherited retinal diseases, hemophilia, and select oncology indications. The growing emphasis on vector...0 Comments 0 Shares 97 Views
More Results
Bangla